Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Cannabis Law Report

DECEMBER 8, 2021

Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Comprehensive access to over 780 Psychiatry deal records. Under what conditions can the deal be terminated? Access Psychiatry deal headline, upfront, milestone and royalty data.

Access 52

Access Data Pharmaceutical Research and Development 52

NORML

APRIL 30, 2020

The call for comments, posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 346

Chronic Pain Clinical Trials Data Patients 346

NORML

JANUARY 31, 2019

Seventy-five percent of military veterans say that they would consider using either “cannabis or cannabinoid products as a treatment option,” according to member survey data compiled by the group Iraq and Afghanistan Veterans of America (IAVA). The organization represents over 400,000 veterans nationwide.

Clinical Trials 192

Clinical Trials Chronic Pain Data Treatment 192

Cannabis Law Report

AUGUST 20, 2022

CHICAGO — Governor JB Pritzker and the Illinois Department of Financial and Professional Regulation (IDFPR) today issued three additional Conditional Adult Use Dispensing Organization Licenses to applicants selected in lotteries held in the summer of 2021. Secretary of the Illinois Department of Financial and Professional Regulation.

Conditions 52

Conditions Dispensary Programs Business 52

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. “That’s not really available in the cannabis industry,” he explained on the Cannabis Enigma podcast. Produced by Elana Goldberg and Michael Schaeffer Omer-Man.

Data 100

Data Research and Development Patients Strains 100

SpeedWeed

MARCH 14, 2021

Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Today, databases, predictive analytics, artificial intelligence , and machine learning are having widespread effects on cannabis businesses, investors, regulators, and consumers. Reduce costs.

Data 52

Data Research and Development Marijuana Collective 52

Cannabis Law Report

AUGUST 23, 2022

A panel of Commonwealth Court judges has ordered the Wolf administration to reveal how many medical marijuana patients have received approval from a doctor to use cannabis for opioid addiction treatment. Qualifying conditions include anxiety disorders, severe chronic pain and epilepsy.

Data 52

Data Treatment Patients Chronic Pain 52

MMJ Recs

MAY 3, 2024

With its program in full swing, thousands of patients across the state are benefiting from access to this alternative form of treatment. From chronic pain to PTSD, patients with qualifying medical conditions have found solace in medical marijuana where traditional treatments may have fallen short.

Marijuana 52

Marijuana Treatment Compliance Compliance 52

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo. .”

Clinical Trials 253

Clinical Trials Chronic Pain Cannabinoids Patients 253

Cannabis Law Report

JUNE 23, 2021

Sapphire Medical Clinics presented six abstracts focused on the latest research on cannabinoids based on data from the UK Medical Cannabis Registry during the 31st Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS2021). PROGRAMME.and.ABSTRACTS. Patient-reported outcomes. Improved quality of life.

Cannabinoids 59

Cannabinoids Data Chronic Pain Sleep 59

NORML

NOVEMBER 25, 2019

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”

Chronic Pain 282

Chronic Pain Patients Therapy Data 282

Cannabis Law Report

AUGUST 23, 2021

The TGA recently released a new medical cannabis dashboard detailing a variety of information on both SAS-A and SAS-B approvals. They announced that they’re ‘committed to ongoing transparency and will release additional datasets in the future’, such as data on Authorised Prescriber applications and the concentrations of active ingredients.

Chronic Pain 105

Chronic Pain Concentrates Conditions Data 105

Veriheal

DECEMBER 14, 2023

There is a persistent and common belief throughout society that using cannabis over an extended period of time (or, in some cases, even once) can lead to a decline in mental abilities and function. The results were pleasing – researchers found no significant difference in cognitive ability before and after participants consumed cannabis.

Chronic Pain 120

Chronic Pain Consumption Cannabis Marijuana 120

NORML

JUNE 10, 2020

The agency’s call for comments, initially posted on April 17 at regulations.gov here , states: “Interested persons or organizations are invited to participate by submitting written views, recommendations, and data related to perspectives on and experiences with pain and pain management. percent in 2016).”

Chronic Pain 242

Chronic Pain Therapy Patients Topical 242

Medicinal Marijuana Association

FEBRUARY 10, 2024

With over 100 known cannabinoids in cannabis, staying informed about the latest research is crucial for making informed decisions. But where do you begin when it comes to navigating the ever-evolving landscape of cannabis studies? Key Takeaways Stay updated with reliable sources to understand latest cannabis research.

Research and Development 52

Research and Development Data Chronic Pain Conditions 52

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. Threat to Patient Access in Oregon.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

AUGUST 14, 2019

Let’s take a closer look at five key ways big data and technology are directly impacting the industry. Big Data Streamlines the Marijuana Regulatory Process and Helps Close the Scientific Research Gap. Therefore, the growing marijuana market lacks the clinical data needed to help marijuana businesses create new and better products.

Data 45

Data Research and Development Marijuana Collective 45

The Cannigma

MARCH 14, 2023

During the height of cannabis prohibition, admitting consumption was very risky. Not only was the identity of “cannabis consumer” tied to stereotypes such as laziness , lack of success and ambition and “a motivational syndrome”, it could result in incarceration and the strict collateral sanctions associated with a drug charge.

Policy 96

Policy Research and Development Conditions Consumption 96

Veriheal

JANUARY 1, 2024

As debates heat up over recreational cannabis, all eyes turn to Ohio and its potential legalization. Once strictly prohibited nationwide, cannabis legislation has evolved remarkably across the U.S. For Ohio, sitting on the fence is becoming less tenable as neighboring states greenlight cannabis sales. in recent years.

Recreational 101

Recreational Supply Chain Legislation Cannabis 101

Illinois News Joint

MAY 12, 2023

With Illinois’ 103rd General Assembly session adjourning Friday, May 19, lawmakers are making their final push for legislation, including a cannabis omnibus. If the omnibus is agreed upon and is attached to a different Senate bill for passage, all cannabis related amendments in the omnibus would pass. Illinois has 17 such regions.

Packaging 99

Packaging Agriculture Cannabis Cultivation 99

Veriheal

SEPTEMBER 13, 2022

The legal cannabis industry in the United States has slowly expanded over the last decade. Despite the federal illegality of cannabis, lawmakers and state representatives have implemented successful medical and recreational cannabis programs across the nation. Homegrown Cannabis Statistics: Supplies, Growers and Products .

Cultivation 108

Cultivation Data DEA Dispensary 108

PrestoDoctor

SEPTEMBER 6, 2023

The legalization of cannabis in some countries and states has brought about significant changes in the healthcare industry. However, with the increasing popularity of cannabis, many people are turning to marijuana as a safer and better alternative for pain management.

Chronic Pain 105

Chronic Pain Research and Development Patients Cannabis 105

Cannabis Law Report

JUNE 5, 2021

Argentina may soon have a regulated cannabis and hemp industry. On Wednesday, Argentina’s Minister of Productive Development, Matías Kulfas , presented a bill titled, “Regulatory framework for the development of the medical cannabis and hemp industry ,” within the framework of the Economic and Social Council.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

AUGUST 24, 2022

Here’s what they say – nothing that any cannabis user hasn’t know since the 19080’s ! Results from the third Cannabis as Medicine study. The third Cannabis as Medicine Survey (CAMS20) follows on from CAMS16 and CAMS18, and includes 1,600 people using medical cannabis between September 2020 and January 2021.

Medicine 52

Medicine Legalization Chronic Pain Access 52

Veriheal

AUGUST 17, 2022

Cannabis’ impact on health is a subject area rife with misunderstanding and controversy. Recently, a study found that cannabis users are more likely to end up needing emergency care, claiming that “cannabis use is not as benign and safe as some might think.” Cannabis Consumers at the Hospital .

Research and Development 96

Research and Development Topical Data Cannabis 96

Veriheal

AUGUST 15, 2022

Cannabis, a plant wrongly accused of causing laziness and tiredness in consumers, could actually offer fatigue-fighting benefits. This is according to a group of researchers from the University of New Mexico (UNM) , who recently teamed up with the creators of the Releaf App to investigate the true link between cannabis use and energy levels.

Treatment 80

Treatment Research and Development Sativa Cannabinoids 80

Veriheal

DECEMBER 9, 2021

When cannabis legalization began to gain ground and support, those who remained opposed to these policy changes touted claims that legalization would increase the risk of mental illness or even suicide among affected populations. We found that recreational marijuana access was associated with a 6.29 Building on Previous Findings.

Legalization 98

Legalization Research and Development Consumption Recreational 98

Cannabis Law Report

AUGUST 27, 2021

On August 19, 2021, the New Jersey Cannabis Regulatory Commission (CRC) approved the Specially Adopted Personal Use Cannabis Rules (the “Rules”). The Rules establish the recreational cannabis industry in New Jersey and allow the CRC to begin licensing businesses as soon as possible.

Cultivation 105

Cultivation Conditions Business Cannabis 105

Cannabis Law Report

MAY 10, 2022

Anxiety and sleep disorders were some reasons given for prescriptions despite lack of evidence for cannabis treatment, researchers find. The researchers’ analysis found anxiety was the reason given for 16% of medicinal cannabis prescriptions. of prescriptions were for sleep disorders.

Medicine 52

Medicine Clinical Trials Data Sleep 52

Veriheal

NOVEMBER 22, 2021

Have you ever wondered who spends more on cannabis: those who consume recreationally or for medicinal purposes? Headset , a leading cannabis data and market intelligence platform, recently conducted an audit of cannabis sales data around the United States—and the discoveries were interesting.

Recreational 89

Recreational Data Dispensary Cannabis 89

Cannabis Cheri

APRIL 1, 2022

Cannabis and Keto, Keto and cannabis. Health, fitness, and cannabis enthusiasts are all singing the praises of combining cannabis and the keto diet. However, when it comes to cannabis and the keto diet, many people claim they actually enhance each other’s health benefits. 6 Keto and Cannabis Edibles 6.1

Edibles 203

Edibles Cannabis Cannabinoids Oil 203

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 105

Consumption Patients Research and Development Data 105

NewsMunchies

JULY 10, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions. Using AI-powered medicine could allow for more effective treatment of conditions such as heart disease, cancer, and cystic fibrosis.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Cannabis Law Report

MAY 10, 2022

First comprehensive study reveals why Australians take medicinal cannabis. First academic study of national medicinal cannabis data. The first in-depth study of Australia’s medicinal cannabis program, which began in 2016, shows the drug is being increasingly prescribed for various conditions. 11 May 2022.

Medicine 52

Medicine Clinical Trials Sleep Data 52

Cannabis Law Report

DECEMBER 9, 2021

Tremor Video , a leading programmatic video and CTV platform, and Fyllo , the leader in compliance-first SaaS solutions for highly regulated industries, today announced a partnership enabling advertisers to target cannabis and CBD consumers across all video screens including programmatic video and Connected TV (CTV).

CBD 52

CBD Data Compliance Compliance 52